Researchers from GeorgeWashingtonUniversity in Washington, D.C., tested an electrochemical sensor that determines the presence of Pseudomonas, a strain of infectious bacteria, by measuring a certain molecule it produces. The test correctly identified the presence of the bacteria 71 percent of the time and was able to detect its absence 57 percent of the time.
“Being able to detect Pseudomonas and other infectious organisms at the time of the clinic visit will greatly enhance our ability to take care of patients,” Victoria Shanmugam, MD, director of the Division of Rheumatology at the GW School of Medicine, said in a statement. “We would not have to wait for culture results before making a decision about antibiotics, and this would allow us to better tailor therapies for our patients.”
The researchers suggest the method could potentially enable clinicians to make more timely and efficient bedside diagnoses that would impact antibiotic prescription and care plans.
More articesl on infection control
NIH researchers identify biomarker of 5 types of cancer
Steroids may help reduce respiratory complications in late term predeliveries, study finds
Fourth UPMC patient with mold infection dies after outbreak
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
